DrugPatentWatch Database Preview
Patents Expiring in 2027
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actelion Pharms | TRACLEER | bosentan | TABLET, FOR SUSPENSION;ORAL | 209279-001 | Sep 5, 2017 | RX | Yes | Yes | Start Trial | Start Trial | Y | ||||
| Chiesi | CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 019734-003 | Jul 31, 2008 | RX | Yes | Yes | Start Trial | Start Trial | Y | ||||
| Chiesi | CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 019734-004 | Nov 7, 2008 | RX | Yes | Yes | Start Trial | Start Trial | Y | ||||
| Chiesi | CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 019734-004 | Nov 7, 2008 | RX | Yes | Yes | Start Trial | Start Trial | Y | ||||
| Chiesi | CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 019734-005 | Nov 7, 2008 | DISCN | Yes | No | Start Trial | Start Trial | Y | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use |
